https://www.selleckchem.com/pr....oducts/sitravatinib-
RAA temporally decreased in patients without LAEs (P0.01); however, RAA remained unchanged throughout the period in patients with LAEs (P=0.16). Moderate or severe pulmonary regurgitation (PR) (hazard ratio [HR], 23.0; 95% confidence interval [CI], 1.3-385; P=0.03) and the ratio of RVA /RAA at 1 year after BPV (HR, 6.3×10 ; 95%CI, 2.1×10 -0.19; P=0.03) were independent risk factors for LAEs. Disproportional right heart growth was observed in patients with PA/IVS after BPV. PR and increased RAA are crucial in identifying